GlassScriptPhysician profile
Priyam Doshi
NPI 1831862358
$1,245.01
in general payments reported to CMS, 2019-2025
14 companies · $93.86 in 2025
The $93.86 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $211 · 2024: $941 · 2025: $93.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.02 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $258.64 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $198.70 | 2023-2025 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $148.75 | 2024 | Spravato, Xarelto |
| Glaxosmithkline, LLC. | $141.09 | 2023-2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $122.18 | 2024 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.14 | 2024 | |
| Astellas Pharma US INC | $79.99 | 2024 | |
| Pfizer INC. | $65.99 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $25.33 | 2025 | Rexulti |
| Abbvie INC. | $24.15 | 2025 | |
| Jazz Pharmaceuticals INC. | $21.63 | 2023 | Xywav |
| Exact Sciences Corporation | $19.41 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $17.04 | 2023 | Eliquis |
| Lilly USA, LLC | $14.97 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyam Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.